Fonar (FONR) AI Stock Analysis

• Market Cap: $116.61M
• Dividend Yield: N/A
• Average Volume (3M): 29.06K
• Price to Earnings (P/E): 14.2
• Beta (1Y): 0.19
• Revenue Growth: 3.36%
• EPS Growth: -21.15%
• Country: US
• Employees: 520
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): 0.31
• Shares Outstanding: 6,173,008
• 10 Day Avg. Volume: 24,606
• 30 Day Avg. Volume: 29,056
• PEG Ratio: -0.59
• Price to Book (P/B): 0.55
• Price to Sales (P/S): 0.91
• P/FCF Ratio: 12.69
• Enterprise Value/Market Cap: 0.87
• Enterprise Value/Revenue: 0.96
• Enterprise Value/Gross Profit: 2.35
• Enterprise Value/Ebitda: 6.20
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 66 Neutral
• Price Target: $20.00 ▲(42.15% Upside)
• Action: Reiterated Date: 02/14/26
• Date: Action: Reiterated 02/14/26

The score is driven primarily by weakening financial performance (sharp TTM revenue decline, margin and cash-conversion pressure, and a loss-making MRI equipment segment) offset by a stable balance sheet and constructive technical momentum. Valuation is moderate but lacks dividend support.

Positive Factors

Recurring diagnostic imaging services model

Fonar’s core revenue comes from operating MRI centers and delivering scans, a recurring service tied to referral relationships, payer billing and collections. This service-based model provides more predictable cash flow than one-off product sales and supports steady operating income over time.

Negative Factors

Sharp TTM revenue decline

A roughly 22% TTM revenue decline is a durable headwind that reduces operating scale and limits fixed-cost absorption. Lower top-line momentum pressures margins, curtails reinvestment capacity in centers or technology, and weakens the company’s ability to execute growth initiatives over the coming quarters.

Fonar Business Overview & Revenue Model

Company Description

Fonar Corporation (FONR) is a medical technology company focused on the development and manufacturing of advanced magnetic resonance imaging (MRI) systems. The company operates primarily in the healthcare sector, providing innovative imaging solut...

Read more

Fonar Corporation (FONR) is a medical technology company focused on the development and manufacturing of advanced magnetic resonance imaging (MRI) systems. The company operates primarily in the healthcare sector, providing innovative imaging solut...

How the Company Makes Money

Fonar generates revenue primarily through the sale of its MRI systems and related equipment to hospitals, diagnostic centers, and medical facilities. The company also earns income from service and maintenance agreements for their MRI machines, pro...

Read more

Fonar generates revenue primarily through the sale of its MRI systems and related equipment to hospitals, diagnostic centers, and medical facilities. The company also earns income from service and maintenance agreements for their MRI machines, pro...

Fonar Financial Statement Overview

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	106.03M	104.35M	102.88M	98.65M	97.59M	89.93M
Gross Profit	43.26M	85.22M	45.14M	45.75M	47.01M	43.47M
EBITDA	16.36M	16.30M	21.13M	24.61M	26.54M	21.18M
Net Income	7.56M	8.33M	10.57M	9.38M	12.44M	10.21M
Balance Sheet
Total Assets	217.22M	216.91M	214.25M	200.58M	199.34M	189.51M
Cash, Cash Equivalents and Short-Term Investments	53.10M	56.45M	56.48M	51.31M	48.76M	44.49M
Total Debt	39.80M	38.92M	41.68M	37.01M	38.22M	34.69M
Total Liabilities	54.36M	56.80M	57.46M	49.75M	53.11M	54.14M
Stockholders Equity	177.23M	172.61M	165.97M	157.91M	150.29M	138.42M
Cash Flow
Free Cash Flow	5.72M	7.45M	13.27M	10.13M	10.67M	14.27M
Operating Cash Flow	9.22M	11.26M	14.09M	14.47M	15.30M	19.09M
Investing Cash Flow	-4.01M	-3.80M	-850.74K	-4.34M	-5.18M	-4.82M
Financing Cash Flow	-5.82M	-7.47M	-8.18M	-7.57M	-5.86M	-6.61M

Fonar Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 14.07
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FONR, the sentiment is Positive. The current price of 14.07 is below the 20-day moving average (MA) of 18.47, below the 50-day MA of 18.55, and below the 200-day MA of 16.21, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 59.02 is Neutral, neither overbought nor oversold. The STOCH value of 89.95 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FONR.

Fonar Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VMD	80 Outperform	$357.07M	19.35	10.87%	―	18.90%	29.22%
FONR	66 Neutral	$116.61M	14.16	4.34%	―	3.36%	-21.15%
XTNT	66 Neutral	$77.42M	17.28	3.77%	―	16.88%	―
CTKB	52 Neutral	$555.34M	-9.70	-18.01%	―	-2.18%	-30.96%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
NNOX	47 Neutral	$140.91M	-4.35	-32.46%	―	15.19%	-3.32%
VREX	46 Neutral	$449.59M	52.93	-13.86%	―	4.14%	-45.29%

Fonar Corporate Events